Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 4Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Lung Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thymus Neoplasms 1Thymoma 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Sarcoma 1Rectal Neoplasms 1Pancreatitis 1Pancreatic Diseases 1Neoplasms, Germ Cell and Embryonal 1Mesothelioma 1Medulloblastoma 1Head and Neck Neoplasms 1Glioma 1Epilepsy 1Ependymoma 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Carcinoma, Lobular 1Bone Neoplasms 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 58Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Drug Therapy 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4Palliative Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Neoplasms × Histocompatibility Testing × Clear all
NCT00152659 2023-04-26

Developing Criteria for Cortical Resections

University of Chicago

Completed
87 enrolled

Epilepsy, Neoplasms

NCT04804878 2021-03-18

MSMTCC

Morehouse School of Medicine

Recruiting
5,000 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡